Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase isozyme II (CA II) is a cytosolic enzyme that catalyzes the reversible hydration of carbon dioxide (CO₂) to bicarbonate (HCO₃⁻) and protons (H⁺). It plays a key role in pH regulation, respiration, ion transport, and various physiological processes. Deficiency or mutations in CA II cause osteopetrosis with renal tubular acidosis. Overexpression or altered expression has been observed in neovessels within certain cancers. It's found highly expressed in red blood cells, renal tubules, gastric mucosa, pancreatic cells, brain oligodendrocytes, choroid plexus epithelium, and myelin sheaths.
Catalyzes the reversible hydration of carbon dioxide (CO₂) to bicarbonate (HCO₃⁻) and protons (H⁺).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase Isozyme II (CA II).